A mutation in SRSF2, SF3B1, U2AF1, ZRSR2, ASXL1, EZH2, BCOR, or STAG2 was found to be >95% specific for s-AML diagnosis. This evidence concerns the gene ZRSR2 and acute myeloid leukemia.